http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022115952-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d7b5c6fdd4dac190eb625b9d1332a1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate | 2021-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab8e66357cba841bf536afd9548ed9ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39aa101843086ee726e247afa562011b |
| publicationDate | 2022-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2022115952-A1 |
| titleOfInvention | [1-(4-chloro-benzoyl)-5-methoxy-2-methyl-1h-indol-3-yl]-acetic acid 4-thiocarbamoyl-phenyl ester for the treatment of a viral infection |
| abstract | The present application relates to methods of treating or preventing a viral infection or treating or preventing a viral infection in a subject in need thereof by administering an effective amount of a compound of Formula I, (I), or a pharmaceutically acceptable salt, prodrug and/or solvate thereof to a subject in need thereof. For example, the viral infection is a coronavirus infection including a severe acute respiratory syndrome (SARS)-related coronavirus infection, a Middle East respiratory syndrome (MERS)-related coronavirus infection, and a coronavirus infection causing common colds; a respiratory syncytial virus (RSV) infection, an influenza virus infection or African swine fever virus (ASFV) infection. The present application also includes methods treating or preventing more or more diseases caused by a viral infection using compounds of Formula (I), or a pharmaceutically acceptable salt, prodrug and/or solvate thereof, wherein the one or more diseases caused by a viral infection are selected from coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome (SARS), Middle East respiratory syndrome, common cold, influenza and African swine fever. |
| priorityDate | 2020-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 547.